NCT07286474

Brief Summary

This clinical trial aims to evaluate the efficacy of low-level laser therapy (LLLT) in conjunction with oral vitamin D3 supplementation in accelerating orthodontic tooth movement in adults with crowded mandibular anterior teeth undergoing orthodontic treatment. Additionally, the study seeks to assess the safety profile and potential adverse effects, including pain and root resorption. The primary research questions are as follows:

  • A blood test to assess baseline vitamin D levels.
  • Placement of orthodontic braces.
  • Daily administration of vitamin D3 supplements for those assigned to the relevant groups, commencing with a loading dose one week prior to the initiation of orthodontic treatment.
  • Application of LLLT to the gingival tissues for participants in the corresponding group, administered at the start and during follow-up visits.
  • Regular clinic visits every four weeks for monitoring, pain assessment, and measurement of tooth movement until the completion of orthodontic alignment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Dec 2026

First Submitted

Initial submission to the registry

December 2, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

December 2, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

LLLT, vitamin D3 supplements, randomized controlled trial, mandibular crowding, root resorption, pain perception, acceleration of orthodontics

Outcome Measures

Primary Outcomes (1)

  • Rate of Orthodontic Tooth Movement

    The rate of reduction in mandibular anterior crowding, measured in mm/month using Little's Irregularity Index (sum of linear displacements between contact points of the six mandibular anterior teeth from canine to canine, assessed via dental models). Compared across groups to evaluate acceleration effects.

    From baseline (initiation of alignment) to complete alignment (Little's Irregularity Index reaches 0 mm), assessed every 4 weeks (estimated duration 6-10 months per participant)

Secondary Outcomes (3)

  • Root Resorption

    Baseline and at completion of alignment (estimated 6-10 months)

  • Pain Perception

    Daily for 7 days after each monthly visit, throughout the alignment phase (up to 10 months)

  • Duration of Orthodontic Alignment

    From baseline to complete alignment, monitored every 4 weeks (estimated 6-10 months)

Study Arms (3)

Vitamin D3 Only Group

EXPERIMENTAL

Participants receive standard orthodontic treatment with pre-adjusted edgewise brackets (0.022" MBT prescription) and wire sequencing (0.014" NiTi initial, progressing to 0.017x0.025" SS). Additionally, oral Vitamin D3 supplementation: single loading dose of 50,000 IU one week before treatment, followed by 1,000 IU daily maintenance until alignment completion. No LLLT.

Dietary Supplement: Cholecalciferol (Vit D3)Device: Fixed Orthodontic Appliance

Vitamin D3 + LLLT Group

EXPERIMENTAL

Participants receive standard orthodontic treatment as above. Plus oral Vitamin D3 supplementation (50,000 IU loading one week before, 1,000 IU daily). Plus LLLT using InGaAlAs diode laser (940 nm, 2.5 W, 25.7 J/cm², 30 seconds labially at muco-gingival junction) initiated at alignment start, repeated on days 14 and 30, then every 4 weeks until completion.

Dietary Supplement: Cholecalciferol (Vit D3)Radiation: Low-Level Laser Therapy

Control Group

ACTIVE COMPARATOR

Participants receive only standard orthodontic treatment with pre-adjusted edgewise brackets (0.022" MBT prescription) and wire sequencing (0.014" NiTi initial, progressing to 0.017x0.025" SS). No Vitamin D3 supplementation or LLLT.

Device: Fixed Orthodontic Appliance

Interventions

Cholecalciferol (Vit D3)DIETARY_SUPPLEMENT

Oral cholecalciferol supplementation: initial loading dose of 50,000 IU one week before orthodontic treatment initiation, followed by daily maintenance dose of 1,000 IU until alignment completion. Administered to participants with baseline sufficient Vitamin D levels.

Vitamin D3 + LLLT GroupVitamin D3 Only Group

Diode laser (Biolase 10W 940±10nm, InGaAlAs) with tooth whitening handpiece (spot size 2.8 cm²), wavelength 940 nm, power output 2.5 W, energy density 25.7 J/cm², continuous wave mode. Applied labially in direct contact at mucogingival junction for 30 seconds. Initiated at alignment start, repeated on days 14 and 30, then every 4 weeks until completion. Eye protection worn by operator and participant.

Vitamin D3 + LLLT Group

Pre-adjusted edgewise conventional brackets with 0.022" MBT (McLaughlin Bennett Trevisi) prescription (3M Unitek), bondable 0.022" single slot molar tubes, bonded using Transbond XT light cure material on upper and lower arches. Wire sequencing: initial 0.014" super elastic nickel-titanium (SE-NiTi), followed by 0.016" SE-NiTi, 0.016 x 0.022" SE-NiTi, and finally 0.017 x 0.025" stainless steel wire until alignment completion. Adjustments every 4 weeks.

Control GroupVitamin D3 Only Group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants requiring orthodontic treatment for crowding in the range of 4 to 8 mm in the lower anterior segment.
  • Age range: 18 to 40 years.
  • Angles Class I, II or III malocclusion
  • Fully erupted permanent dentition
  • Good oral and general health
  • \- Normal range of Vitamin D levels

You may not qualify if:

  • Deficiency of Vitamin D levels below normal range. • Medically compromised patients with thyroid, parathyroid, or renal and liver diseases.
  • Patients on medication, especially corticosteroid and anticonvulsant drugs • Poor oral hygiene
  • Pregnancy
  • Lactation
  • History of craniofacial abnormalities or syndromes that may affect orthodontic tooth movements.
  • Participants failing to complete the Vitamin D supplementation log sheets will be excluded to ensure accurate data collection.
  • Inability to comply with the study protocol or unable to complete the study due to personal, medical, or logistical reasons (e.g., missed follow-up visits or failure to undergo assessments) will be excluded to maintain data integrity and minimize biases from incomplete participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Armed Forces Hospital

Madinah, Madinah, 42314, Saudi Arabia

Location

MeSH Terms

Conditions

Root Resorption

Interventions

CholecalciferolLow-Level Light TherapyOrthodontic Appliances, Fixed

Condition Hierarchy (Ancestors)

Tooth ResorptionTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipidsLaser TherapyTherapeuticsPhototherapyOrthodontic AppliancesOrthodonticsDentistry

Study Officials

  • Rozita Hassan, BDS, MS, MOrtho RCSEd

    Universiti Sains Malayisa

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The three study arms in this randomized controlled trial are as follows: * Group 1A (Experimental): Standard orthodontic treatment (braces) plus oral Vitamin D3 supplements (initial 50,000 IU dose one week before treatment, followed by 1,000 IU daily maintenance). * Group 1B (Experimental): Standard orthodontic treatment (braces) plus oral Vitamin D3 supplements (as above) combined with Low-Level Laser Therapy (LLLT) applied to the gums at specified intervals. * Control Group: Standard orthodontic treatment (braces) only, with no Vitamin D3 supplements or LLLT.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

December 2, 2025

First Posted

December 16, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations